Literature DB >> 30135988

[Sexuality in adolescents with rheumatic diseases : Contraception, HPV vaccination and pregnancy].

R Fischer-Betz1, I Haase2, P T Oommen3.   

Abstract

Young patients and adolescents with chronic rheumatic diseases have the same desires, fears and needs in terms of sexuality and pregnancy as their healthy peers. In most cases adolescents are already sexually active before transition from pediatric to adult rheumatological care takes place. Pregnancies in women with rheumatic diseases are associated with increased maternal and fetal risks, especially when they occur unplanned in the course of active disease or under teratogenic drugs. Safe contraception is therefore crucial in preventing unwanted pregnancies. The choice of contraception should anticipate the safety of the method of contraception as well as age-dependent practicability. A strategy of "double protection" through the use of condoms for contraception and prevention of sexually transmitted diseases combined with another safe contraception method should be recommended. Women with rheumatic diseases are more susceptible to acquire persisting human papilloma virus (HPV) infections and the subsequent progression to cervical cancer. In women with rheumatic diseases HPV vaccination induces high seroconversion rates, is safe and does not seem to induce disease activity. The care of adolescent women with rheumatic diseases before, during and after medical transition needs to encompass an open, early and continuous counselling regarding these topics in order to retain the individual health-related quality of life and to adapt this care to age-specific needs.

Entities:  

Keywords:  Cervical cancer; Juvenile idiopathic arthritis; Seroconversion rate; Systemic lupus erythematosus; Transition

Mesh:

Year:  2018        PMID: 30135988     DOI: 10.1007/s00393-018-0522-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  25 in total

1. 

Authors:  Tim Niehues; Christian Bogdan; Jane Hecht; Thomas Mertens; Miriam Wiese-Posselt; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2017-06       Impact factor: 1.513

2.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681

3.  Postpartum complications in new mothers with juvenile idiopathic arthritis: a population-based cohort study.

Authors:  Debbie Ehrmann Feldman; Évelyne Vinet; Marie-Pierre Sylvestre; Beth Hazel; Ciarán Duffy; Anick Bérard; Garbis Meshefedjian; Sasha Bernatsky
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

4.  Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?

Authors:  Jinoos Yazdany; Laura Trupin; Rachel Kaiser; Gabriela Schmajuk; Joann Zell Gillis; Eliza Chakravarty; Eleanor Bimla Schwarz
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-11-15       Impact factor: 4.794

5.  Combined oral contraceptives in women with systemic lupus erythematosus.

Authors:  Michelle Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Lisa R Sammaritano; Michael Lockshin; Joan T Merrill; H Michael Belmont; Anca D Askanase; W Joseph McCune; Michelene Hearth-Holmes; Mary Anne Dooley; Joan Von Feldt; Alan Friedman; Mark Tan; John Davis; Mary Cronin; Betty Diamond; Meggan Mackay; Lisa Sigler; Michael Fillius; Ann Rupel; Frederick Licciardi; Jill P Buyon
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

6.  A trial of contraceptive methods in women with systemic lupus erythematosus.

Authors:  Jorge Sánchez-Guerrero; América G Uribe; Luisa Jiménez-Santana; Marilú Mestanza-Peralta; Pilar Lara-Reyes; Armando H Seuc; María-del-Carmen Cravioto
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

7.  Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Authors:  Jill P Buyon; Mimi Y Kim; Marta M Guerra; Carl A Laskin; Michelle Petri; Michael D Lockshin; Lisa Sammaritano; D Ware Branch; T Flint Porter; Allen Sawitzke; Joan T Merrill; Mary D Stephenson; Elisabeth Cohn; Lamya Garabet; Jane E Salmon
Journal:  Ann Intern Med       Date:  2015-08-04       Impact factor: 25.391

8.  Pregnancy outcomes in women with juvenile idiopathic arthritis: a population-based study.

Authors:  Jian Sheng Chen; Jane B Ford; Christine L Roberts; Judy M Simpson; Lyn M March
Journal:  Rheumatology (Oxford)       Date:  2013-02-04       Impact factor: 7.580

9.  Pregnancy outcome in juvenile systemic lupus erythematosus: a Brazilian multicenter cohort study.

Authors:  Clovis A A Silva; Maria O Hilario; Marilia V Febronio; Sheila K Oliveira; Rozana G Almeida; Adriana R Fonseca; Edson M Yamashita; Marcos V Ronchezel; Luciene L Campos; Simone Appenzeller; Maria V Quintero; Ana B Santos; Ana C Medeiros; Luciana M Carvalho; Teresa C Robazzi; Silvana P Cardin; Eloisa Bonfa
Journal:  J Rheumatol       Date:  2008-04-01       Impact factor: 4.666

10.  Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years.

Authors:  Arzu Soybilgic; Karen B Onel; Tammy Utset; Kenneth Alexander; Linda Wagner-Weiner
Journal:  Pediatr Rheumatol Online J       Date:  2013-08-07       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.